LEADER 04425nam 2200493 450 001 9910270899303321 005 20171107090051.0 010 $a1-119-15257-7 010 $a1-119-15258-5 010 $a1-119-15260-7 035 $a(CKB)4330000000008915 035 $a(MiAaPQ)EBC5106985 035 $a(EXLCZ)994330000000008915 100 $a20171118h20182018 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 00$aCognitive behavioral psychopharmacology $ethe clinical practice of biopsychosocial integration /$fedited by Mark Dana Muse 210 1$aHoboken, New Jersey :$cWiley Blackwell,$d2018. 210 4$dİ2018 215 $a1 online resource (456 pages) $cillustrations 311 $a1-119-15256-9 320 $aIncludes bibliographical references at the end of each chapters and index. 330 $a"Outlines a comprehensive, evidence-based approach to coordinating psychopharmacological and psychotherapeutic treatments. Cognitive Behavioral Psychopharmacology takes an evidence-based approach to demonstrating the advantages of biopsychosocial integration in interventions for the major psychiatric diagnoses. It is the first and only book to translate the current evidence for cognitive behavioral, psychosocial, and pharmacologic approaches to mental health disorders into clear guidance for clinical practice. There is a burgeoning movement in mental health to acknowledge the entire person functioning across physical, psychological and social spheres, and to integrate medical as well as psychological and social interventions to address the entire spectrum of presenting problems. This book bridges a gap in the professional mental health literature on the subject of standalone versus combined treatment approaches. It reviews the current state of integrative care, and makes a strong case that optimal outcomes are best achieved by an awareness of how and why the cognitive-behavioral aspects of prescribed medical and psychological interventions influence treatment. Each disorder-specific chapter is authored by a prescriber and psychotherapist team who consider all the evidence around treatments and combinations, providing outcome conclusions and concise tables of recommended front-line interventions. Provides a biopsychsocial perspective that integrates the medical, psychotherapeutic, family, and community aspects of the therapeutic process Brings together and compares the current evidence for and against treatments that combine psychopharmacology and cognitive behavioral psychotherapy for major psychiatric diagnoses. Outlines an evidence-based approach to determining which combination of treatments is most appropriate for each of the major psychiatric diagnoses. Describes, in a way that is accessible to both prescribers and therapists, when and how cognitive behavioral therapy can be integrated into pharmacotherapy. The book will appeal to a wide range of mental health professionals, including psychologists, psychiatrists, clinical social workers, licensed professional counselors, marriage and family therapists, and addictions counselors. It also will be of interest to primary care physicians and nurse practitioners who work side by side with mental health professionals"--$cProvided by publisher. 330 $a""Evidence-based" is the rallying cry for the entire field of mental health. But, where is the evidence, and what does it say? This volume answers these seminal questions, and provides a method for integrating pharmacological and psychotherapeutic interventions according to that evidence. Indeed, it goes beyond the evidence, and provides a model for blending cognitive behavioral approaches with the judicious use of psychotropic medicine in what the author calls Cognitive Behavioral Psychopharmacology (CBP)"--$cProvided by publisher. 606 $aPsychopharmacology 606 $aCognitive therapy 606 $aPsychotherapy 608 $aElectronic books. 615 0$aPsychopharmacology. 615 0$aCognitive therapy. 615 0$aPsychotherapy. 676 $a615.7/8 686 $aPSY007000$2bisacsh 702 $aMuse$b Mark Dana 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910270899303321 996 $aCognitive behavioral psychopharmacology$92817581 997 $aUNINA